Sanders Morris Harris’s PetMed Express PETS Stock Holding History

Sanders Morris Harris’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,000	Closed	-$220K	–	141
2018 Q2	$220K	Sell	5,000 -215	-4%	-$8.32K	0.1%	115
2018 Q1	$218K	Buy	+5,215	New	+$241K	0.09%	119

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Sanders Morris Harris's PETS Position: Q3 2018 in Review

Sanders Morris Harris sold out of PetMed Express (PETS) in Q3 2018, closing a stake of 5,000 shares — an estimated $220K sold.

Sanders Morris Harris first reported a position in PETS in Q1 2018 and held it in 2 quarters. The position peaked at $220K in Q2 2018. 199 funds tracked by Wall St. Rank hold PETS as of Q3 2018.

Sanders Morris Harris reported no remaining PetMed Express position as of Q3 2018 after selling out during the quarter.
Sanders Morris Harris sold 5,000 PetMed Express shares in Q3 2018, an estimated $220K.
Sanders Morris Harris first reported a position in PetMed Express in Q1 2018 and held it in 2 quarters.
Sanders Morris Harris's PetMed Express position peaked at $220K in Q2 2018.
199 funds tracked by Wall St. Rank held PetMed Express as of Q3 2018.

Based on Sanders Morris Harris's 13F filing for Q3 2018, filed 9 Oct 2018.